Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of the antiphospholipid syndrome.

Literature DB >> 1768171

Management of the antiphospholipid syndrome.

M A Khamashta¹, T Wallington.

Abstract

Mesh：

Substances：
Prednisolone
Aspirin

Year: 1991 PMID： 1768171 PMCID： PMC1004593 DOI： 10.1136/ard.50.12.959

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

20 in total

1. CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS.

Authors: I B SNEDDON
Journal: Br J Dermatol Date: 1965-04 Impact factor: 9.302

2. Pregnancy outcome and autoantibodies in connective tissue disease.

Authors: N J McHugh; P A Reilly; L A McHugh
Journal: J Rheumatol Date: 1989-01 Impact factor: 4.666

3. Antibody to cardiolipin, lupus anticoagulant, and fetal death.

Authors: M D Lockshin; T Qamar; M L Druzin; S Goei
Journal: J Rheumatol Date: 1987-04 Impact factor: 4.666

4. The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors: R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal: Medicine (Baltimore) Date: 1989-11 Impact factor: 1.889

Review 5. Antiphospholipid antibodies and reproduction.

Authors: D A Triplett; E N Harris
Journal: Am J Reprod Immunol Date: 1989 Nov-Dec Impact factor: 3.886

6. Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty.

Authors: R Johnson; J Charnley
Journal: Clin Orthop Relat Res Date: 1979-10 Impact factor: 4.176

7. Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms.

Authors: B J Trudinger; G J Stewart; C M Cook; A Connelly; T Exner
Journal: Obstet Gynecol Date: 1988-08 Impact factor: 7.661

8. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors: R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal: Am J Med Date: 1989-04 Impact factor: 4.965

Management of the antiphospholipid syndrome.

1. CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS.

2. Pregnancy outcome and autoantibodies in connective tissue disease.

3. Antibody to cardiolipin, lupus anticoagulant, and fetal death.

4. The "primary" antiphospholipid syndrome: major clinical and serological features.

Review 5. Antiphospholipid antibodies and reproduction.

6. Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty.

7. Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms.

8. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

9. Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy.

10. Obstetric complications associated with the lupus anticoagulant.

Review 1. Treatment of the antiphospholipid syndrome.

2. Life-threatening right ventricular thrombosis in association with phospholipid antibodies.

Review 3. Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Review 4. Antiphospholipid antibodies in paediatrics.